Takeda
Takeda expands in Singapore
March 3, 2015Manufacturing and Production Singapore, Takeda, biopolis, emerging markets, vaccines
Japanese pharma giant Takeda has set up new Singapore offices in the Biopolis biomedical complex with the aim of expanding …
Takeda acquires Turkish firm Neutec
February 24, 2015Sales and Marketing Takeda, Turkey, gastroenterology, neutec, respiratory, turkish
Takeda has signed an agreement to acquire one of Turkey’s leading pharma firms Neutec in a $120 million deal. The …
Takeda trial hits late-stage buffers
February 17, 2015Research and Development, Sales and Marketing AMG 706, Japan, NSCLC, Takeda, lung cancer, motesanib
Takeda is to scrap an advanced trial of an investigational drug after it failed to show any benefit in survival …
Takeda scraps vaccine trial in Phase II
February 2, 2015Research and Development, Sales and Marketing Diptheria-Tetanus-acellular Pertussis (DTaP) and Sabin inactivated poliovirus vaccine (sIPV), Rajeev Venkayya, TAK-361S, Takeda
Takeda has announced it is abandoning the development of a vaccine in Japan that was in Phase II clinical trials.TAK-361S, …
Interview: Rajeev Venkayya, president of Takeda Vaccine
January 19, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bush, Ebola, Gates, Rajeev Venkayya, Takeda, brett wells, vaccines
Rajeev Venkayya is the president of the global vaccine business unit at Takeda Pharmaceuticals. He has served as special assistant …
Takeda trials Teva Parkinson’s drug in Japan
January 9, 2015Sales and Marketing Azilect, CHMP, Copaxone, Parkinson's, Takeda, rasagiline
Takeda has begun late stage trials for Teva’s Parkinson’s disease drug Azilect in Japan, with the hopes of bringing the …
NICE rejects Takeda Crohn’s disease drug
December 23, 2014Sales and Marketing Crohn’s disease, Entyvio, NHS, NICE, Takeda, crohn's disease, vedolizumab
Takeda has seen its treatment for people with Crohn’s disease Entyvio rejected by NICE in an initial appraisal. The healthcare …
Takeda takes senior head from Sanofi
December 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Takeda, andrew plump
Dr Andrew Plump will be joining Takeda in February from Sanofi to lead its global R&D operations as chief medical …
GSK Ebola vaccine gets EU support
December 17, 2014Research and Development, Sales and Marketing EC, EU, Ebola, Europe, GSK, Merck, Takeda, Vaccine, WHO, johnson
A newly-formed European consortium is to help advance the development of GlaxoSmithKline’s promising Ebola vaccine. The consortium is backed by …
Takeda eyes new drug licences following positive blood cancer studies
December 11, 2014Research and Development, Sales and Marketing Adcetris, Takeda, Velcade, ash, bortezomib, brentuximab vedotin, hematology
Takeda is bringing its biotech arm in-house to create a global oncology business unit, which it says will drive forward …
Analysis finds no Actos bladder cancer link
December 8, 2014Sales and Marketing Actos, Cancer, Takeda, bladder, lilly, pioglitazone, type 2
A large-scale analysis of patient data has found that pioglitazone, the diabetes drug that is the subject of ongoing safety …
GSK Ebola vaccine ‘promising’ in early trials
November 27, 2014Research and Development, Sales and Marketing Africa, Ebola, GSK, Takeda, Vaccine, WHO, vaccines
The first trial results for GlaxoSmithKline’s (GSK) Ebola vaccine candidate have shown that the medicine was well-tolerated and produced an …
GE and Takeda make liver pact
November 13, 2014Research and Development, Sales and Marketing GE Healthcare, Japan, Takeda, US, liver, nafld, nash
GE Healthcare and Takeda Pharmaceutical have joined forces to develop treatments which target liver conditions including non-alcoholic fatty liver disease …
Takeda hires Merck senior head as president
November 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, marc princen
Marc Princen has joined Takeda Pharmaceuticals from Merck and is to serve as its corporate officer and president of the …
Takeda and Lilly get Actos trial reprieve
October 29, 2014Sales and Marketing Actos, Takeda, bladder cancer, diabetes, lilly
A judge has dramatically reduced the $9 billion damages bill Takeda and Lilly were set to pay over safety allegations …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
